ArticleJournal of clinical medicine2022
Preventive Impella
Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 28 citations in OpenAlex.
- Temporary Mechanical Circulatory Support in Patients in Cardiogenic Shock Requiring Cardiac Surgery: Protected Cardiac Surgery Concept.Journal of clinical medicine · 2026Review
- Transaxillar Impella Implantation: Learning Curve Analysis and the Role of Mentorship in Accelerating Proficiency.Journal of clinical medicine · 2026Article
- Optimal surgical management of patients with severely reduced left ventricular ejection fraction undergoing coronary artery bypass grafting.Heart and vessels · 2026Article
- How I Do It: Perioperative Use of Micro-Axial Pumps in High Risk Coronary Artery Bypass Grafting: The Early Johns Hopkins Experience.Journal of cardiovascular development and disease · 2026Article
- Coronary Artery Bypass Surgery in a Patient With an Occluded Abdominal Aorta Supported by Microaxial Left Ventricular Assist Device.Annals of thoracic surgery short reports · 2026Article
- Myocardial Revascularization in 2025: A Clinical Perspective on the Evolution of Technologies, Strategic Decision-Making, and Future Horizons.Reviews in cardiovascular medicine · 2026Review
- Left Ventricular Venting during On-Pump Beating-Heart Coronary Artery Bypass Grafting for Advanced Ischemic Cardiomyopathy: A Surgical Strategy to Achieve Complete Revascularization.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2026Article
- Perioperative temporary microaxial left ventricular assist device support in patients with low ejection fraction undergoing coronary artery bypass grafting.Frontiers in cardiovascular medicine · 2026Article
- Circulatory Support for High-Risk Coronary Artery Bypass Grafting and Coronary Interventions: Where is the Evidence?The International journal of angiology : official publication of the International College of Angiology, Inc · 2025Review
- The role of temporary mechanical circulatory support in heart failure.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- Perioperative mechanical circulatory support: transitioning from sequential to parallel recovery.Perioperative medicine (London, England) · 2025Article
- Impella 5.5 for Preoperative Optimization in the Setting of Ruptured Papillary Muscle.The Thoracic and cardiovascular surgeon reports · 2025Article
- Trajectories following Impella 5.5 support are associated with initial presentation acuity.Artificial organs · 2025Article
- Preemptive Direct Aortic Insertion of Impella 5.5 in Patients Undergoing Cardiac or Aortic Surgery.Annals of thoracic surgery short reports · 2024Article
- The use of perioperative Impella 5.5 support in high-risk cardiac surgery: a retrospective cohort study.Journal of thoracic disease · 2024Article
- Low Left-Ventricular Ejection Fraction as a Predictor of Intraprocedural Cardiopulmonary Resuscitation in Patients Undergoing Transcatheter Aortic Valve Implantation.Life (Basel, Switzerland) · 2024Article
- Propensity score-based comparison of high-risk coronary artery bypass grafting vs. left ventricular assist device implantation in patients with coronary artery disease and advanced heart failure.Frontiers in cardiovascular medicine · 2024Article
- Foreword.Interventional cardiology (London, England) · 2024Article
- Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgery.JTCVS open · 2023Article
- Role of acute mechanical circulatory support devices in cardiogenic shock.Indian journal of thoracic and cardiovascular surgery · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 2 countries.
Funding
Abstract
backgroundPatients with severely reduced LV-EF ≤ 30% undergoing CABG have a high risk for postoperative cardiogenic shock. The optimal timing of an adequate hemodynamic support has an impact on short- and midterm mortality after CABG. This study aimed to assess the prophylactic use of the Impella pump in high-risk patients undergoing elective cardiac surgery.
methodsIn this single-center retrospective study, 14 patients with LV-EF (≤30%) undergoing cardiac surgery received a prophylactic, perioperative Impella (5.0, 5.5) support between 2020 and 2022.
resultsThe mean age at surgery was 64.2 ± 2.6 years, the mean preoperative LV-EF was 20.7% ± 1.56%. The duration of Impella support was 4 (3-7.8) days and the 30-day survival rate was 92.85%. Acute renal failure occurred in four patients who were dialyzed on average for 1.2 ± 0.7 days. Mechanical ventilation was needed for 1.75 (0.9-2.7) days. Time to inotrope/vasopressor independence was 2 (0.97-7.25) days with a highest lactate level (24 h postoperatively) of 3.8 ± 0.6 mmol/l. Postoperative LV-EF showed a significant improvement when compared to preoperative LV-EF (29.1% ± 2.6% vs. 20.7% ± 1.56% (
conclusionThe prophylactic Impella application seems to be a safe approach to improve the outcomes of this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.